Evaluation of the Moisturizing Effect of Study Product AV0018B and the Persistence of This Effect After Repeated Applications, Compared to an Untreated Control Area.

Inclusion Criteria: * Females * Aged 20 to 55 years, inclusive * Phototype I to V, inclusive * Low hairiness and absence of prominent veins on the internal and posterointernal side of the forearms. * No shaving/hair removal of forearms * Dehydrated forearms, with HI ≤ 35 (posterointernal side of the forearms) * Not taking part in another clinical research study. * Having signed the consent form. * Having health insurance. Exclusion Criteria: Population: * Pregnant, breastfeeding women. * Subjects declaring to have hot flushes. * With sunburn on forearms. * Frequently washing their forearms for professional reasons or out of habit. * Application of keratolytic and/or self-tanning products to the upper limbs in the 4 weeks prior to inclusion. * Application of skin care (Hydrating, nourishing) or exfoliating products to the upper limbs in the 2 weeks prior to inclusion. * Application of water or hygiene products to the upper limbs since the last wash on the evening before inclusion. * Participating in another study on the forearms (not including kinetics studies) in the 2 weeks prior to inclusion. * Participating in a kinetics study on the forearms in the 48 hours prior to inclusion. * Subjects unable to comply with the protocol requirements. * Subjects deprived of freedom through a legal or administrative decision, or in care or under legal guardianship. Diseases: * History of allergy to any of the investigational product ingredients * Skin lesions or skin disease on the hands, arms and forearms. * Type 1 diabetes. * Unresolved viral hepatitis. * Chronic cardiovascular, endocrine, rheumatological and urogenital system and non-stabilized neuropsychiatric disorders (treatment started less than 2 months ago). * Acute pathology (infectious, inflammatory). * Dermatological condition or skin lesion on the top of the cheekbone liable to interfere with the samplings according to the investigator's opinion. * Any skin characteristic on the top of the cheekbone incompatible with the samplings (raised nevus, etc.) according to the investigator's opinion. Treatments: * Ongoing local treatment (dermocorticosteroids, retinoids, antibiotics, antifungals, etc.) or treatment applied in the 7 days prior to inclusion. * Ongoing oral antibiotic and/or anti-inflammatory (steroid and non-steroid) or treatment taken for more than 5 consecutive days in the week before inclusion. * Oral treatment (cardiovascular, endocrine, rheumatological, urogenital, neuropsychiatric, immunosuppressant) started in the 2 months prior to inclusion. * Any local treatment applied to the face in the week preceding the inclusion visit * Application of water, any rinsed or leave-on cleansing or care product on the face after the last wash performed the day before the inclusion visit